Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1
about
Induction of P-450 in workers exposed to dioxinCytochrome P450 isoform selectivity in human hepatic theobromine metabolismDetermination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeineEthnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.Coffee consumption, genetic susceptibility and bladder cancer risk.Caffeine metabolism in patients with chronic liver disease.Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.Metabolism of theophylline by cDNA-expressed human cytochromes P-450.Cell-based systems to assess nuclear receptor activation and their use in drug development.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.The relevance of theobromine for the beneficial effects of cocoa consumption.Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples.PharmGKB summary: caffeine pathway.Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese populationGenome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAMCoffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.Drug interactions involving ethanol and alcoholic beverages.Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake.Development of an IgY Antibody-Based Immunoassay for the Screening of the CYP2E1 Inhibitor/Enhancer from Herbal Medicines.Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order.Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery.Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man.Are the Current Guidelines on Caffeine Use in Sport Optimal for Everyone? Inter-individual Variation in Caffeine Ergogenicity, and a Move Towards Personalised Sports Nutrition.Multiscale modeling reveals inhibitory and stimulatory effects of caffeine on acetaminophen-induced toxicity in humans.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations.Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study.Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease.Clinical importance of hepatic cytochrome P450 in drug metabolism.Cytochrome P450 monooxygenases and interactions of psychotropic drugs: a five-year update.Biotransformation of caffeine by cDNA-expressed human cytochromes P-450.Drug-mediated inactivation of cytochrome P450.
P2860
Q23923467-C14BEFA1-487B-4A8C-8600-10060642F252Q24564968-8D550EC6-66BC-4266-AA30-BA10DF98F977Q28610002-6C30E616-F5D0-47B0-B369-6B3F64D4BD94Q30396823-59048CDF-05AA-4E70-A025-6A90EEBD5AB0Q34031319-19366081-12B9-4459-B230-B40B3358CC8AQ34302436-CA63689C-7AD5-4FBA-853F-A1828E52828EQ34346940-F8286451-E63A-4B3B-86B3-F1078929C70DQ34347072-3AC89BDF-A30A-4D81-B9AC-DF6E4D48EDBCQ34553662-0D6AA084-7D9F-41D1-89DA-92A41DB7D363Q35015993-057139A8-6247-405B-B5D8-443EC6214A26Q35104091-5696A7C7-4A20-404C-82FC-4766962FF5D6Q36053371-E215447D-2BCD-469B-BCC1-1BA294232097Q36054907-00F039EE-A5BF-45FF-B04B-0A650910991CQ36055051-858FBCF7-E47F-4131-BAFA-A6D1971AC0D7Q36352038-917180CD-FAD4-4C01-9E6B-430FFEF8A102Q36567463-A2220E7A-C920-4895-8902-CA28B12B6303Q36960553-56F93718-4204-46E7-B970-FC0880B1AF12Q37157901-991B785C-E676-4F2A-8C24-05286187FF4EQ37315406-DAB718C6-BF73-4589-8C5F-654A7591AA4DQ37525547-082F26EB-479D-4C41-82FE-234E8831F1EFQ37948134-CEF107C4-8913-4DD2-8E3B-EC1C788594DBQ38103885-A948F3F4-BC30-4E18-B04D-F8284CD508DDQ38176575-F2391602-7C2C-43A3-AEED-A701E7EDB473Q38211210-3F9DEE4D-2250-41B9-9495-89E1CE439BD1Q38214488-884C5E6F-5E7C-4AFF-8CE5-C50BD4F7896EQ38564572-D32DBF38-73F5-4477-B1A4-432167A41BC4Q38635751-09EB684A-EEA6-4493-8561-E7CF008B305EQ38994159-06C1D2F6-0AAF-418A-8904-F6022059E328Q39157059-D468F604-121F-47FA-AD44-12B78A5FEEF7Q39357279-DBA7FDDE-E5C6-4125-83AE-51F03119EA31Q39558046-F6D28F30-4DC6-49EE-BF50-C770E7580BB7Q39782469-F703E143-BC14-494C-9D90-B4E09BFA8FB6Q39891907-65286853-094D-44B4-9943-93235618D3DDQ40554461-C8798B3B-7EFC-4FCA-B2D4-23D669BEE27FQ40700838-391E2D69-9E9D-4186-9F2B-036E6266C26EQ40775732-BBB6F88A-A0FF-44A2-9F22-7D48A3E02EABQ40923015-697FC659-D6B4-4381-9094-B1E286FB79BEQ40949311-AEA419C3-C73E-479D-8957-C711A3824929Q41247453-9F2E20D2-66D4-4D8C-8D2E-528F634825CCQ41555359-DE7CFE31-C3BC-4C64-AD61-36442DDD8C4B
P2860
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@ast
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@en
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@nl
type
label
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@ast
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@en
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@nl
prefLabel
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@ast
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@en
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@nl
P2093
P3181
P1476
Biotransformation of caffeine, ...... ressed human CYP1A2 and CYP2E1
@en
P2093
P3181
P356
10.1097/00008571-199204000-00004
P407
P577
1992-04-01T00:00:00Z